Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 423

1.

Long-term assessment of intrarenal blood flow with Doppler ultrasonography for hypertensive patients after percutaneous transluminal renal angioplasty.

Abe M, Araya K, Akaishi T, Miki T, Miki M, Sugawara A, Abe T, Ishii T, Ito S.

Hypertens Res. 2019 May 31. doi: 10.1038/s41440-019-0272-0. [Epub ahead of print] No abstract available.

PMID:
31150020
2.

Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study.

Ito S, Itoh H, Rakugi H, Okuda Y, Yamakawa S.

J Hum Hypertens. 2019 May 21. doi: 10.1038/s41371-019-0207-x. [Epub ahead of print]

PMID:
31113987
3.

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.

Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N, Mise K, Yamaguchi H, Nakamura T, Asaji K, Mukawa C, Tsukamoto H, Sato T, Oikawa Y, Iwasaki T, Oe Y, Tsukimi T, Fukuda NN, Ho HJ, Nanto-Hara F, Ogura J, Saito R, Nagao S, Ohsaki Y, Shimada S, Suzuki T, Toyohara T, Mishima E, Shima H, Akiyama Y, Akiyama Y, Ichijo M, Matsuhashi T, Matsuo A, Ogata Y, Yang CC, Suzuki C, Breeggemann MC, Heymann J, Shimizu M, Ogawa S, Takahashi N, Suzuki T, Owada Y, Kure S, Mano N, Soga T, Wada T, Kopp JB, Fukuda S, Hozawa A, Yamamoto M, Ito S, Wada J, Tomioka Y, Abe T.

Nat Commun. 2019 Apr 23;10(1):1835. doi: 10.1038/s41467-019-09735-4.

4.

18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.

Tezuka Y, Yamazaki Y, Kitada M, Morimoto R, Kudo M, Seiji K, Takase K, Kawasaki Y, Mitsuzuka K, Ito A, Nishikawa J, Asai N, Nakamura Y, Gomez-Sanchez CE, Ito S, Dezawa M, Sasano H, Satoh F.

Hypertension. 2019 Jun;73(6):1283-1290. doi: 10.1161/HYPERTENSIONAHA.118.12064.

PMID:
31006333
5.

A 29-year-old Woman with Recurrent Pregnancy-induced Hypertension Based on Vascular Compression of the Medulla Oblongata.

Akaishi T, Kiyomoto H, Abe M, Okuda H, Ishizawa K, Endo T, Miyata M, Nakayama K, Ito S, Tominaga T, Ishii T.

Intern Med. 2019 Apr 17. doi: 10.2169/internalmedicine.2382-18. [Epub ahead of print]

6.

ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration.

Hirose T, Cabrera-Socorro A, Chitayat D, Lemonnier T, Féraud O, Cifuentes-Diaz C, Gervasi N, Mombereau C, Ghosh T, Stoica L, Bacha JDA, Yamada H, Lauterbach MA, Guillon M, Kaneko K, Norris JW, Siriwardena K, Blasér S, Teillon J, Mendoza-Londono R, Russeau M, Hadoux J, Ito S, Corvol P, Matheus MG, Holden KR, Takei K, Emiliani V, Bennaceur-Griscelli A, Schwartz CE, Nguyen G, Groszer M.

J Clin Invest. 2019 Apr 15;130:2145-2162. doi: 10.1172/JCI79990. eCollection 2019 Apr 15.

7.

JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.

Nakamura S, Hasebe N, Yatabe M, Kishi T, Ishida M, Ichihara A, Node K, Ishimitsu T, Itoh H, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nishiyama A, Higaki J, Miura K, Rakugi H, Kawano Y, Tamura K, Yatabe T, Ohya Y, Ito S.

Hypertens Res. 2019 Apr 8. doi: 10.1038/s41440-019-0261-3. [Epub ahead of print] No abstract available.

PMID:
30962519
8.

Viewpoint on Guidelines for Treatment of Hypertension in Japan.

Hirawa N, Umemura S, Ito S.

Circ Res. 2019 Mar 29;124(7):981-983. doi: 10.1161/CIRCRESAHA.119.314991. No abstract available.

PMID:
30920921
9.

High glucose level and angiotensin II type 1 receptor stimulation synergistically amplify oxidative stress in renal mesangial cells.

Akaishi T, Abe M, Okuda H, Ishizawa K, Abe T, Ishii T, Ito S.

Sci Rep. 2019 Mar 26;9(1):5214. doi: 10.1038/s41598-019-41536-z.

10.

Effects of sodium-glucose cotransporter 2 inhibitors on hypoglycaemia in brittle diabetic patients with decreased endogenous insulin secretion.

Ogawa S, Nako K, Ito S.

Endocrinol Diabetes Metab. 2018 Dec 1;2(1):e00044. doi: 10.1002/edm2.44. eCollection 2019 Jan.

11.

Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury.

Oe Y, Fushima T, Sato E, Sekimoto A, Kisu K, Sato H, Sugawara J, Ito S, Takahashi N.

Sci Rep. 2019 Feb 27;9(1):2986. doi: 10.1038/s41598-019-39914-8.

12.

Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria: A Randomized, Controlled Trial.

Ito S, Kagawa T, Saiki T, Shimizu K, Kuroda S, Sano Y, Umeda Y.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):354-363. doi: 10.2215/CJN.07720618. Epub 2019 Feb 12.

PMID:
30755452
13.

Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.

Imaruoka K, Oe Y, Fushima T, Sato E, Sekimoto A, Sato H, Sugawara J, Ito S, Takahashi N.

Biochem Biophys Res Commun. 2019 Mar 19;510(4):587-593. doi: 10.1016/j.bbrc.2019.01.110. Epub 2019 Feb 7.

PMID:
30739788
14.

A Catastrophic Case of Idiopathic Cholesterol Crystal Embolism with Multiple Lethal Complications: A Labyrinth Underneath the Diagnosis of Skin Ulcers in Chronic Kidney Disease Patients.

Kumakura S, Nakamichi T, Suzuki N, Yamakage S, Ishikawa A, Fujikura E, Sato S, Aoki T, Musha H, Kikuchi K, Nagasawa T, Sato H, Ito S, Miyazaki M.

Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2378-18. [Epub ahead of print]

15.

Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.

Watanabe M, Oe Y, Sato E, Sekimoto A, Sato H, Ito S, Takahashi N.

Am J Physiol Renal Physiol. 2019 Apr 1;316(4):F654-F659. doi: 10.1152/ajprenal.00489.2018. Epub 2019 Jan 23.

PMID:
30672316
16.

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.

Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA; Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.

PMID:
30635226
17.

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.

Coresh J, Heerspink HJL, Sang Y, Matsushita K, Arnlov J, Astor BC, Black C, Brunskill NJ, Carrero JJ, Feldman HI, Fox CS, Inker LA, Ishani A, Ito S, Jassal S, Konta T, Polkinghorne K, Romundstad S, Solbu MD, Stempniewicz N, Stengel B, Tonelli M, Umesawa M, Waikar SS, Wen CP, Wetzels JFM, Woodward M, Grams ME, Kovesdy CP, Levey AS, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium and Chronic Kidney Disease Epidemiology Collaboration.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127. doi: 10.1016/S2213-8587(18)30313-9. Epub 2019 Jan 8.

PMID:
30635225
18.

Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Chang AR, Grams ME, Ballew SH, Bilo H, Correa A, Evans M, Gutierrez OM, Hosseinpanah F, Iseki K, Kenealy T, Klein B, Kronenberg F, Lee BJ, Li Y, Miura K, Navaneethan SD, Roderick PJ, Valdivielso JM, Visseren FLJ, Zhang L, Gansevoort RT, Hallan SI, Levey AS, Matsushita K, Shalev V, Woodward M; CKD Prognosis Consortium (CKD-PC).

BMJ. 2019 Jan 10;364:k5301. doi: 10.1136/bmj.k5301.

19.

Low-energy extracorporeal shock wave ameliorates ischemic acute kidney injury in rats.

Yoshida M, Nakamichi T, Mori T, Ito K, Shimokawa H, Ito S.

Clin Exp Nephrol. 2019 May;23(5):597-605. doi: 10.1007/s10157-019-01689-7. Epub 2019 Jan 7.

PMID:
30617840
20.

JSH Statement: Kyoto declaration on hypertension research in Asia.

Ito M, Ishimitsu T, Ichihara A, Itoh H, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Node K, Hasebe N, Higaki J, Miura K, Rakugi H, Tamura K, Kawano Y, Yatabe T, Ohya Y, Ito S.

Hypertens Res. 2019 Jun;42(6):759-760. doi: 10.1038/s41440-018-0172-8. Epub 2019 Jan 7. No abstract available.

PMID:
30617311

Supplemental Content

Loading ...
Support Center